eClinical Technology and Industy News

Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time

First-of-its-kind technology stack in autoimmune diseases.

Provides unprecedented insights into optimal patient treatment pathway.

Excerpt from the Press Release:

WALTHAM, Mass. (January 10, 2023) – ScipherMedicine, a precision immunology company matching each patient with their most effective therapy, has acquired Philadelphia-based data, analytics, and software company CrossBridge to bolster its data and analytics capabilities.

The acquisition gives Scipher new data management and analytics capabilities to enable a more granular and real-time understanding of patients’ treatment pathway. CrossBridge’s SaaS value-based care platform bridges gaps between patients, providers, payers, and improves health outcomes and lowers the cost of care for autoimmune disease patients. The transaction has closed, and terms were not disclosed.

There is a significant need to better understand how and when to apply various therapeutic and diagnostic interventions to improve the treatment pathway for patients,” said Scipher’s Chief Executive Officer Alif Saleh. “To date, we have not had a platform combining critical patient molecular, clinical and claims data as autoimmune diseases, including rheumatoid arthritis.

Click the button below to read the entire Press Release:

Continue Reading The Press Release

Discover What Sets TrialStat Apart From Ordinary EDC Platforms

Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?

Archives